Saad Naaman, MD
Physical Medicine & Rehabilitation · Troy, MINPI 1225137334
Payments from drug & device makers
Across 80 payments — averaging $19.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$251
- AbbVie$234
- Avanir Pharmaceuticals, Inc.$167
- Corcept Therapeutics$125
- Lilly USA, LLC$98
- Pfizer$91
- plus $591 from 19 others
What the payments were for
- Food & beverage$1,557100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 15 | $251 |
| AbbVie | 7 | $234 |
| Avanir Pharmaceuticals, Inc. | 11 | $167 |
| Corcept Therapeutics | 1 | $125 |
| Lilly USA, LLC | 5 | $98 |
| Pfizer | 6 | $91 |
| Shield Therapeutics Inc | 4 | $74 |
| Abbott | 3 | $59 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $46 |
| Actelion Pharmaceuticals US, Inc. | 3 | $45 |
| Boston Scientific | 2 | $43 |
| Boehringer Ingelheim | 2 | $41 |
| Exact Sciences | 2 | $39 |
| Merck | 2 | $36 |
| Aimmune Therapeutics, Inc. | 2 | $34 |
| Bayer | 2 | $33 |
| Amarin Pharma, Inc. | 2 | $28 |
| Dexcom, Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| UCB, Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Amryt Pharma Holdings Ltd | 1 | $13 |
| Lucid Diagnostics Inc. | 1 | $13 |
| GSK | 1 | $13 |
| Acadia Pharmaceuticals Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,557 in reported general payments places this provider in the 80th percentile of 469 physical medicine & rehabilitation providers in Michigan.
See all physical medicine & rehabilitation providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 67 | $1,582 |
| Duloxetine Hcl | 43 | $703 |
| Diclofenac Sodium | 31 | $648 |
| Tramadol Hcl | 30 | $612 |
| Pregabalin | 21 | $559 |
| Gabapentin | 67 | $434 |
| Pantoprazole Sodium | 24 | $335 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 15 | $249 |
| Carvedilol | 17 | $219 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $161 |
| Metoprolol Tartrate | 17 | $129 |
| Atorvastatin Calcium | 13 | $126 |
| Furosemide | 33 | $126 |
| Famotidine | 17 | $118 |
| Trazodone Hcl | 25 | $64 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Troy
- Jason PeterTroy$20K
- Edward DabrowskiRoseville$392K
- Gianna Maria RodriguezAnn Arbor$136K
- Alecia DaunterAnn Arbor$83K
- Johnathan HoDearborn$65K
- Erika ErlandsonAnn Arbor$54K
- David WeingardenClinton Township$34K
- Jonathan VandenbergGrand Rapids$34K
- Mathew SaffarianEast Lansing$24K
- Randolph RussoGrand Rapids$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.